About Tract Pharmaceuticals, Inc.
Tract Bio is a biotechnology company focused on developing novel therapies for cancer and inflammatory diseases using its proprietary stemECHO technology, which enables the cloning of epithelial stem cells for precise disease mechanism studies and targeted treatments.
Proprietary stemECHO technology for cloning epithelial stem cells with genetic integrityDevelopment of tumor-activated peptide-drug-conjugate (PDC) technology for targeted cancer and inflammatory disease treatmentsPipeline of preclinical and clinical assets for cancer therapeuticsDiscovery of drugs targeting pathogenic stem cells in inflammatory and cancerous conditions
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to Tract Pharmaceuticals, Inc. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.